Wednesday, March 07, 2018 1:00:14 PM
"Arrayit microarray technology life sciences customer $8.0 billion life sciences leader Bio-Rad Laboratories NYSE:BIO beats on total and segment revs in Q4-2017 indicating life sciences market strength per top analyst Tim Evans at Wells Fargo"
So why hasn't "top analyst" Tim Evans of Wells Fargo never ever mentioned ARYC in any report? Inquiring minds want to know.
Could it be because ARYC is an also ran, after 25 years in the business?
Be careful folks. What appears to be too good to be true, usually is.
Sad but true.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM